カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の膵臓がん診断市場2023-2030：製品別、検査種類別（イメージング検査、生検、血液検査、その他）、がん種類別（外分泌、内分泌）、エンドユーザー別、地域別

【英語タイトル】Pancreatic Cancer Diagnostic Market Size, Share & Trends Analysis Report By Product, By Test Type (Imaging Test, Biopsy, Blood Test, Others), By Cancer Type (Exocrine, Endocrine), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23JUN084）・商品コード：GRV23JUN084
・発行会社（調査会社）：Grand View Research
・発行日：2023年5月31日
・ページ数：150
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Grand View Research社の市場調査書によると、世界の膵臓がん診断市場規模が、予測期間中に年平均6.53％増加し、2030年までに39億ドルへ達すると見込まれています。本調査書では、膵臓がん診断の世界市場を調査対象とし、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、製品別（器具、消耗品、サービス）分析、検査種類別（イメージング検査、生検、血液検査、その他）分析、がん種類別（外分泌、内分泌）分析、エンドユーザー別（病院、診療所、研究所、その他）、地域別（北米、ヨーロッパ、アジア太平洋中南米、中東・アフリカ）分析、競争状況などについて調査・分析し、まとめています。なお、こちらに掲載されている企業情報には、QIAGEN、Illumina, Inc.、BD、Thermo Fisher Scientific, Inc.、Myriad Genetics, Inc.、Agilent Technologies, Inc.、F. Hoffmann-La Roche Ltd.、Hitachi, Ltd、Koninklijke Philips N.V.、Abbott、Danaher、Prestige Biopharma Ltd.、BioMarker Strategies、ASURAGEN, INCなどが含まれています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界膵臓がん診断の市場規模：製品別
- 器具の市場規模
- 消耗品の市場規模
- サービスの市場規模
・世界膵臓がん診断の市場規模：検査種類別
- イメージング検査における市場規模
- 生検における市場規模
- 血液検査における市場規模
- その他検査における市場規模
・世界膵臓がん診断の市場規模：がん種類別
- 外分泌性がんにおける市場規模
- 内分泌性がんにおける市場規模
・世界膵臓がん診断の市場規模：エンドユーザー別
- 病院エンドユーザーにおける市場規模
- 診療所エンドユーザーにおける市場規模
- 研究所エンドユーザーにおける市場規模
- その他エンドユーザーにおける市場規模
・世界膵臓がん診断の市場規模：地域別
- 北米の膵臓がん診断市場規模
- ヨーロッパの膵臓がん診断市場規模
- アジア太平洋の膵臓がん診断市場規模
- 中南米の膵臓がん診断市場規模
- 中東・アフリカの膵臓がん診断市場規模
・競争状況

膵臓がん診断市場の成長と動向

Grand View Research社の最新レポートによると、世界の膵臓がん診断市場規模は2030年までに39億米ドルに達する見込みです。さらに、予測期間中のCAGRは6.53%で拡大すると推定されます。革新的な製品の導入と、疾病の早期診断ニーズの高まり、高度な診断ソリューション開発のための研究活動の活発化が、世界市場を牽引すると予測されています。

例えば、2021年8月、Immunovia, Inc.は、IMMray PanCan-d検査を用いた膵臓がんの患者検査を開始する承認をマサチューセッツ州公衆衛生局から取得しました。IMMray PanCan-d検査は、膵臓がんの早期発見のために開発された検査です。同市場は、研究資金の増加、診断検査の技術的進歩、精密検査ソリューションの開発に対するメーカーの努力の高まりにより、有利な成長機会を得ると予測されています。例えば、2022年12月、Bluestar Genomics, Inc.は、膵臓がんの早期発見のための最大規模の臨床試験の開始を発表しました。

さらに、世界的な疾病負担を軽減するために、新規の自動化された正確な診断ソリューションの開発に対する需要が近年高まっています。新規バイオマーカー同定、膵臓がんへのナノ粒子利用、診断プロセスへの人工知能（AI）導入に関連する研究は、成長を促進する要因であると予測されています。また、画像病理検査やバイオマーカー検査にAIを取り入れることで、膵臓がんを検出するための診断検査の導入が促進されます。

例えば、富士通は2022年4月、CTスキャンから膵臓の悪性腫瘍を早期に検出するAIソリューションを開発するため、福島の南東北総合病院と提携しました。効果的で先進的な診断ツールの製造に向けた主要な市場参入企業による投資の増加や、各社が実施するさまざまな戦略的イニシアティブは、市場拡大の新たな道を切り開く可能性が高いです。例えば、2023年3月、Prestige Biopharma Limitedは、膵臓がんを検出するためのクラス初の診断キットを開発しました。この検査は、早期段階での診断に役立ち、治療成績と生存率を世界的に向上させます。

同様に、診断ツールに対する有利な規制枠組みも市場拡大を支える要因の一つです。例えば、2023年1月、米国FDAはOverC Multi-Cancer Detection Blood Test（MCDBT）に対して、平均的および中程度のリスクを有する成人の肺がん、肝臓がん、食道がん、膵臓がんなど、さまざまな形態のがんの早期診断のための画期的医療機器指定を与えました。

膵臓がん診断市場レポートハイライト

– 診断手順における消耗品の採用増加、研究開発投資の増加、技術的に先進的な診断キットや試薬の発売事例の増加により、消耗品分野が2022年に最大の売上シェアを占めました。

– 画像検査セグメントは、医療従事者が膵臓がんを早期に発見・診断できること、腫瘍の位置を特定する画像モジュールの選好性が高いことから、2022年に最大の市場収益シェアを占めました。

– 最終用途別では、病院分野が2022年に市場の首位に立ちましたが、検査室セグメントが予測期間中に最も急成長する分野と予測されます。

– アジア太平洋地域は、患者集団の高いアンメットニーズと主要市場プレイヤーの投資増加により、予測期間中に最も速い成長を示すとみられています。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Test Segment
1.1.1.2 Service Provider Segment
1.1.1.3 Application Segment
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective – 1
1.4.2 Objective – 2
1.4.3 Objective – 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 GVR’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Pancreatic Cancer Diagnostic Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Increasing prevalence of pancreatic cancer
3.2.1.2 Growing demand for advanced diagnostic solutions
3.2.2 Market restraint analysis
3.2.2.1 High cost of diagnostic tests and stringent regulatory framework
3.3 Market Analysis Tools
3.3.1 Industry analysis – Porter’s Five Forces
3.3.2 PESTLE analysis
Chapter 4 Pancreatic Cancer Diagnostic Market Segment Analysis, By Product, 2018 – 2030 (USD Million)
4.1 Definition and Scope
4.2 Product Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Global Pancreatic Cancer Diagnostic Market, by Product, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Instruments
4.5.1.1 Instruments market estimates and forecast, 2018 – 2030 (USD Million)
4.5.2 Consumables
4.5.2.1 Consumables market estimates and forecast, 2018 – 2030 (USD Million)
4.5.3 Services
4.5.3.1 Services market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 5 Pancreatic Cancer Diagnostic Market Segment Analysis, By Test Type 2018 – 2030 (USD Million)
5.1 Definition and Scope
5.2 Test Type Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global Pancreatic Cancer Diagnostic Market, by Test Type, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Imaging Test
5.5.1.1 Imaging test market estimates and forecast, 2018 – 2030 (USD Million)
5.5.1.2 CT Scan
5.5.1.2.1 CT scan market estimates and forecast, 2018 – 2030 (USD Million)
5.5.1.3 MRI
5.5.1.3.1 MRI market estimates and forecast, 2018 – 2030 (USD Million)
5.5.1.4 Ultrasound
5.5.1.4.1 Ultrasound market estimates and forecast, 2018 – 2030 (USD Million)
5.5.1.5 PET
5.5.1.5.1 PET market estimates and forecast, 2018 – 2030 (USD Million)
5.5.1.6 Others
5.5.1.6.1 Others market estimates and forecast, 2018 – 2030 (USD Million)
5.5.2 Biopsy
5.5.2.1 Biopsy market estimates and forecast, 2018 – 2030 (USD Million)
5.5.3 Blood Test
5.5.3.1 Blood test market estimates and forecast, 2018 – 2030 (USD Million)
5.5.3.2 Liver Function Tests
5.5.3.2.1 Liver function tests market estimates and forecast, 2018 – 2030 (USD Million)
5.5.3.3 Tumor Markers
5.5.3.3.1 Tumor markers market estimates and forecast, 2018 – 2030 (USD Million)
5.5.3.4 Others
5.5.3.4.1 Others market estimates and forecast, 2018 – 2030 (USD Million)
5.5.4 Others
5.5.4.1 Others market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 6 Pancreatic Cancer Diagnostic Market Segment Analysis, By Cancer Type, 2018 – 2030 (USD Million)
6.1 Definition and Scope
6.2 Cancer Type Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Global Pancreatic Cancer Diagnostic Market, by Cancer Type, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Exocrine
6.5.1.1 Exocrine cancer market estimates and forecast, 2018 – 2030 (USD Million)
6.5.1.2 Adenocarcinoma
6.5.1.2.1 Adenocarcinoma market estimates and forecast, 2018 – 2030 (USD Million)
6.5.1.3 Squamous Cell Carcinoma
6.5.1.3.1 Squamous cell carcinoma market estimates and forecast, 2018 – 2030 (USD Million)
6.5.1.4 Adenosquamous Carcinoma
6.5.1.4.1 Adenosquamous carcinoma market estimates and forecast, 2018 – 2030 (USD Million)
6.5.1.5 Colloid Carcinoma
6.5.1.5.1 Colloid carcinoma market estimates and forecast, 2018 – 2030 (USD Million)
6.5.2 Endocrine
6.5.2.1 Endocrine cancer market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 7 Pancreatic Cancer Diagnostic Market Segment Analysis, By End-use, 2018 – 2030 (USD Million)
7.1 Definition and Scope
7.2 End-use Market Share Analysis, 2022 & 2030
7.3 Segment Dashboard
7.4 Global Pancreatic Cancer Diagnostic Market, by End-use, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Hospitals
7.5.1.1 Hospitals market estimates and forecast, 2018 – 2030 (USD Million)
7.5.2 Clinics
7.5.2.1 Clinics market estimates and forecast, 2018 – 2030 (USD Million)
7.5.3 Laboratories
7.5.3.1 Laboratories market estimates and forecast, 2018 – 2030 (USD Million)
7.5.4 Others
7.5.4.1 Others market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 8 Pancreatic Cancer Diagnostic Market Segment Analysis, By Region, 2018 – 2030 (USD Million)
8.1 Definition & Scope
8.2 Regional Market Share Analysis, 2022 & 2030
8.3 Regional Market Dashboard
8.4 Regional Market Snapshot
8.5 SWOT Analysis
8.5.1 North America
8.5.2 Europe
8.5.3 Asia Pacific
8.5.4 Latin America
8.5.5 Middle East & Africa
8.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
8.6.1 North America
8.6.1.1 North America pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.1.2 U.S.
8.6.1.2.1 Key Country Dynamics
8.6.1.2.2 Competitive Scenario
8.6.1.2.3 Regulatory Framework
8.6.1.2.4 Reimbursement Scenario
8.6.1.2.5 U.S. pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.1.3 Canada
8.6.1.3.1 Key Country Dynamics
8.6.1.3.2 Competitive Scenario
8.6.1.3.3 Regulatory Framework
8.6.1.3.4 Reimbursement Scenario
8.6.1.3.5 Canada pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.2 Europe
8.6.2.1 Europe pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.2.2 UK
8.6.2.2.1 Key Country Dynamics
8.6.2.2.2 Competitive Scenario
8.6.2.2.3 Regulatory Framework
8.6.2.2.4 Reimbursement Scenario
8.6.2.2.5 UK pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.2.3 Germany
8.6.2.3.1 Key Country Dynamics
8.6.2.3.2 Competitive Scenario
8.6.2.3.3 Regulatory Framework
8.6.2.3.4 Reimbursement Scenario
8.6.2.3.5 Germany pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.2.4 Spain
8.6.2.4.1 Key Country Dynamics
8.6.2.4.2 Competitive Scenario
8.6.2.4.3 Regulatory Framework
8.6.2.4.4 Reimbursement Scenario
8.6.2.4.5 Spain pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.2.5 France
8.6.2.5.1 Key Country Dynamics
8.6.2.5.2 Competitive Scenario
8.6.2.5.3 Regulatory Framework
8.6.2.5.4 Reimbursement Scenario
8.6.2.5.5 France pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.2.6 Italy
8.6.2.6.1 Key Country Dynamics
8.6.2.6.2 Competitive Scenario
8.6.2.6.3 Regulatory Framework
8.6.2.6.4 Reimbursement Scenario
8.6.2.6.5 Italy pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.2.7 Denmark
8.6.2.7.1 Key Country Dynamics
8.6.2.7.2 Competitive Scenario
8.6.2.7.3 Regulatory Framework
8.6.2.7.4 Reimbursement Scenario
8.6.2.7.5 Denmark pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.2.8 Sweden
8.6.2.8.1 Key Country Dynamics
8.6.2.8.2 Competitive Scenario
8.6.2.8.3 Regulatory Framework
8.6.2.8.4 Reimbursement Scenario
8.6.2.8.5 Sweden pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.2.9 Norway
8.6.2.9.1 Key Country Dynamics
8.6.2.9.2 Competitive Scenario
8.6.2.9.3 Regulatory Framework
8.6.2.9.4 Reimbursement Scenario
8.6.2.9.5 Norway pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.3 Asia Pacific
8.6.3.1 Asia Pacific pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.3.2 Japan
8.6.3.2.1 Key Country Dynamics
8.6.3.2.2 Competitive Scenario
8.6.3.2.3 Regulatory Framework
8.6.3.2.4 Reimbursement Scenario
8.6.3.2.5 Japan pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.3.3 China
8.6.3.3.1 Key Country Dynamics
8.6.3.3.2 Competitive Scenario
8.6.3.3.3 Regulatory Framework
8.6.3.3.4 Reimbursement Scenario
8.6.3.3.5 China pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.3.4 India
8.6.3.4.1 Key Country Dynamics
8.6.3.4.2 Competitive Scenario
8.6.3.4.3 Regulatory Framework
8.6.3.4.4 Reimbursement Scenario
8.6.3.4.5 India pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.3.5 South Korea
8.6.3.5.1 Key Country Dynamics
8.6.3.5.2 Competitive Scenario
8.6.3.5.3 Regulatory Framework
8.6.3.5.4 Reimbursement Scenario
8.6.3.5.5 South Korea pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.3.6 Australia
8.6.3.6.1 Key Country Dynamics
8.6.3.6.2 Competitive Scenario
8.6.3.6.3 Regulatory Framework
8.6.3.6.4 Reimbursement Scenario
8.6.3.6.5 Australia pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.3.7 Thailand
8.6.3.8.1 Key Country Dynamics
8.6.3.8.2 Competitive Scenario
8.6.3.8.3 Regulatory Framework
8.6.3.8.4 Reimbursement Scenario
8.6.3.8.5 Thailand pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.4 Latin America
8.6.4.1 Latin America pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.4.2 Brazil
8.6.4.2.1 Key Country Dynamics
8.6.4.2.2 Competitive Scenario
8.6.4.2.3 Regulatory Framework
8.6.4.2.4 Reimbursement Scenario
8.6.4.2.5 Brazil pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.4.3 Mexico
8.6.4.3.1 Key Country Dynamics
8.6.4.3.2 Competitive Scenario
8.6.4.3.3 Regulatory Framework
8.6.4.3.4 Reimbursement Scenario
8.6.4.3.5 Mexico pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.4.4 Argentina
8.6.4.4.1 Key Country Dynamics
8.6.4.4.2 Competitive Scenario
8.6.4.4.3 Regulatory Framework
8.6.4.4.4 Reimbursement Scenario
8.6.4.4.5 Argentina pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.5 MEA
8.6.5.1 MEA pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.5.2 South Africa
8.6.5.2.1 Key Country Dynamics
8.6.5.2.2 Competitive Scenario
8.6.5.2.3 Regulatory Framework
8.6.5.2.4 Reimbursement Scenario
8.6.5.2.5 South Africa pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.5.3 Saudi Arabia
8.6.5.3.1 Key Country Dynamics
8.6.5.3.2 Competitive Scenario
8.6.5.3.3 Regulatory Framework
8.6.5.3.4 Reimbursement Scenario
8.6.5.3.5 Saudi Arabia pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.5.4 UAE
8.6.5.4.1 Key Country Dynamics
8.6.5.4.2 Competitive Scenario
8.6.5.4.3 Regulatory Framework
8.6.5.4.4 Reimbursement Scenario
8.6.5.4.5 UAE pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
8.6.5.5 Kuwait
8.6.5.5.1 Key Country Dynamics
8.6.5.5.2 Competitive Scenario
8.6.5.5.3 Regulatory Framework
8.6.5.5.4 Reimbursement Scenario
8.6.5.5.5 Kuwait pancreatic cancer diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 9 Pancreatic Cancer Diagnostic Market – Competitive Landscape
9.1 Recent Developments & Impact Analysis, by Key Market Participants
9.1.1 Ansoff matrix
9.1.2 Heat map analysis
9.1.3 Major Deals and Strategic Alliances Analysis
9.1.3.1 Joint Ventures
9.1.3.2 Licensing Agreements
9.1.3.3 Product Launches
9.1.3.4 Conferences and Campaigns
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.3 Vendor Landscape
9.3.1 List of key distributors and channel partners
9.3.2 Key customers
9.4 Public Companies
9.4.1 Competitive Dashboard Analysis
9.4.1.1 Market Differentiators
9.5 Private Companies
9.5.1 List of key emerging companies
9.6 Company Profiles
9.6.1 QIAGEN
9.6.1.1 Company overview
9.6.1.2 Financial performance
9.6.1.3 Product benchmarking
9.6.1.4 Strategic Initiatives
9.6.2 Illumina, Inc.
9.6.2.1 Company overview
9.6.2.2 Financial performance
9.6.2.3 Product benchmarking
9.6.2.4 Strategic Initiatives
9.6.3 BD
9.6.3.1 Company overview
9.6.3.2 Financial performance
9.6.3.3 Product benchmarking
9.6.3.4 Strategic Initiatives
9.6.4 Thermo Fisher Scientific, Inc.
9.6.4.1 Company overview
9.6.4.2 Financial performance
9.6.4.3 Product benchmarking
9.6.4.4 Strategic Initiatives
9.6.5 Myriad Genetics, Inc.
9.6.5.1 Company overview
9.6.5.2 Financial performance
9.6.5.3 Product benchmarking
9.6.5.4 Strategic Initiatives
9.6.6 Agilent Technologies, Inc.
9.6.6.1 Company overview
9.6.6.2 Financial performance
9.6.6.3 Product benchmarking
9.6.6.4 Strategic Initiatives
9.6.7 F. Hoffmann-La Roche Ltd.
9.6.7.1 Company overview
9.6.7.2 Financial performance
9.6.7.3 Product benchmarking
9.6.7.4 Strategic initiatives
9.6.8 Hitachi, Ltd
9.6.8.1 Company overview
9.6.8.2 Financial performance
9.6.8.3 Product benchmarking
9.6.8.4 Strategic initiatives
9.6.9 Koninklijke Philips N.V.
9.6.9.1 Company overview
9.6.9.2 Financial performance
9.6.9.3 Product benchmarking
9.6.9.4 Strategic initiatives
9.6.10 Abbott
9.6.10.1 Company overview
9.6.10.2 Financial performance
9.6.10.3 Product benchmarking
9.6.10.4 Strategic initiatives
9.6.11 Danaher
9.6.11.1 Company overview
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.11.4 Strategic initiatives
9.6.12 Prestige Biopharma Ltd.
9.6.11.1 Company overview
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.11.4 Strategic initiatives
9.6.13 BioMarker Strategies
9.6.11.1 Company overview
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.11.4 Strategic initiatives
9.6.14 ASURAGEN, INC
9.6.11.1 Company overview
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.11.4 Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 Global Pancreatic Cancer Diagnostic Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 6 Global Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 7 Global Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 8 Global Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 9 North America Pancreatic Cancer Diagnostic Market, By Country, 2018 - 2030 (USD Million)
Table 10 North America Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 11 North America Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 12 North America Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 13 North America Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 14 U.S. Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 15 U.S. Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 16 U.S. Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 17 U.S. Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 18 Canada Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 19 Canada Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 20 Canada Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 21 Canada Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 22 Europe Pancreatic Cancer Diagnostic Market, By Country, 2018 - 2030 (USD Million)
Table 23 Europe Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 24 Europe Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 25 Europe Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 26 Europe Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 27 UK Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 28 UK Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 29 UK Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 30 UK Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 31 Germany Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 32 Germany Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 33 Germany Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 34 Germany Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 35 France Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 36 France Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 37 France Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 38 France Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 39 Italy Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 40 Italy Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 41 Italy Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 42 Italy Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 43 Spain Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 44 Spain Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 45 Spain Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 46 Spain Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 47 Denmark Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 48 Denmark Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 49 Denmark Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 50 Denmark Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 51 Norway Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 52 Norway Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 53 Norway Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 54 Norway Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 55 Sweden Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 56 Sweden Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 57 Sweden Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 58 Sweden Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Pancreatic Cancer Diagnostic Market, By Country, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 63 Asia Pacific Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 64 Japan Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 65 Japan Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 66 Japan Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 67 Japan Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 68 China Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 69 China Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 70 China Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 71 China Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 72 India Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 73 India Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 74 India Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 75 India Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 76 South Korea Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 77 South Korea Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 78 South Korea Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 79 South Korea Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 80 Australia Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 81 Australia Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 82 Australia Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 83 Australia Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 84 Thailand Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 85 Thailand Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 86 Thailand Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 87 Thailand Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 88 Latin America Pancreatic Cancer Diagnostic Market, By Country, 2018 - 2030 (USD Million)
Table 89 Latin America Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 90 Latin America Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 91 Latin America Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 92 Latin America Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 93 Brazil Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 94 Brazil Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 95 Brazil Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 96 Brazil Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 97 Argentina Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 98 Argentina Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 99 Argentina Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 100 Argentina Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 101 Mexico Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 102 Mexico Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 103 Mexico Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 104 Mexico Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 105 Middle East and Africa Pancreatic Cancer Diagnostic Market, By Country, 2018 - 2030 (USD Million)
Table 106 Middle East and Africa Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 107 Middle East and Africa Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 108 Middle East and Africa Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 109 Middle East and Africa Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 110 South Africa Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 111 South Africa Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 112 South Africa Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 113 South Africa Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 117 Saudi Arabia Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 118 UAE Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 119 UAE Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 120 UAE Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 121 UAE Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 122 Kuwait Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 123 Kuwait Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 124 Kuwait Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 125 Kuwait Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)

★調査レポート[世界の膵臓がん診断市場2023-2030：製品別、検査種類別（イメージング検査、生検、血液検査、その他）、がん種類別（外分泌、内分泌）、エンドユーザー別、地域別] (コード：GRV23JUN084)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の膵臓がん診断市場2023-2030：製品別、検査種類別（イメージング検査、生検、血液検査、その他）、がん種類別（外分泌、内分泌）、エンドユーザー別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の卵巣がん診断市場2023-2030：診断種類別（画像診断、血液検査、生検、その他）、がん種類別（上皮性腫瘍、間質細胞腫瘍、胚細胞腫瘍、その他）、エンドユーザー別（病院研究所、がん診断センター、研究機関、その他）、地域別
  • 世界の腎機能検査市場2023-2030：製品別（クリアランス検査、血液検査、尿検査、希釈・濃縮検査薬、その他）、エンドユーザー別、地域別
  • 世界の子癇前症診断市場2022-2029：検査種類別（血液検査、尿分析）、製品別（機器、消耗品）、エンドユーザー別（病院、専門クリニック、診断センター、その他）、地域別
  • 世界の微小残存病変（MRD）検査市場2023-2030：技術別（次世代シーケンシング（NGS）、ポリメラーゼ連鎖反応（PCR））、がん種類別（血液学的悪性腫瘍）、エンドユーザー別（病院）、地域別
  • 世界のペット用DNA検査市場2023-2030：検査種類別（遺伝性疾患、ヘルス・ウェルネス）、動物種類別（犬、猫）、サンプル種類別（血液、唾液）、エンドユーザー別
  • 世界の前立腺がん診断薬市場（2023-2030）：検査種類別（予備検査、確認検査）、種類別（腺がん、間質細胞がん）、エンドユーザー別（病院、外来施設）、地域別
  • 世界の乳がん診断市場2023-2030：製品別（プラットフォームベース、機器ベース）、種類別（画像診断、生検、ゲノム検査、血液検査）、用途別、エンドユーザー別、地域別
  • 世界の肝臓がん診断市場2023-2030：検査種類別（臨床検査、イメージング、内視鏡検査、生検）、エンドユーザー別、地域別
  • 世界の子宮頸がん診断市場2023-2030：検査種類別（パップテスト/細胞診検査、HPV検査、コルポスコピー、子宮頸部生検）、年齢層別、エンドユーザー別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆